Summary
Latest filing:
Peter J. Facchini is Chief Innovation Officer of Enveric Biosciences, Inc. (ENVB). 2 SEC Form 4 filings on record going back to 2024, most recently on 3 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Peter J. Facchini has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Peter J. Facchini's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
- Jason P. Rhodes - $124.92M of DYN open-market activity in the last 12 months
- Matthew Rabinowitz - $124.05M of NTRA open-market activity in the last 12 months
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Peter J. Facchini?
Peter J. Facchini is a corporate insider, tracked as Chief Innovation Officer of Enveric Biosciences, Inc. (ENVB). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Peter J. Facchini last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 2 filings going back to 2024.
Where can I see all of Peter J. Facchini's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Peter J. Facchini and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
